STOCK TITAN

Silvaco (NASDAQ: SVCO) boosts at-the-market stock offering capacity to $35M

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Silvaco Group, Inc. expanded its at-the-market common stock offering program to a total of $35.0 million under its existing Open Market Sale Agreement with Jefferies LLC. This includes an additional $20.0 million capacity above the previously registered amount.

As of May 7, 2026, the company had sold 752,744 shares for approximately $4,331,280, leaving up to $30,668,720 of common stock available to be offered and sold. Based on a share price of $12.46 and 14,066,661 non‑affiliate shares, the public float was $175,270,596, so Silvaco is no longer subject to the “baby shelf” limitation and may now use General Instruction I.B.1 of Form S‑3.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Total ATM capacity $35.0 million Aggregate at-the-market offering size after May 8, 2026 supplement
Incremental ATM increase $20.0 million Additional at-the-market capacity added by new prospectus supplement
Shares sold under ATM 752,744 shares Common stock sold through at-the-market program as of May 7, 2026
Proceeds from ATM sales $4,331,280 Aggregate offering price of shares sold via at-the-market program
Remaining ATM capacity $30,668,720 Maximum additional common stock value that may be sold
Public float value $175,270,596 Public float calculated under Form S-3 General Instruction I.B.6
Share price used for float $12.46 per share Sale price on Nasdaq Global Select Market on May 6, 2026
Non-affiliate shares 14,066,661 shares Common shares held by non-affiliates used to compute public float
Open Market Sale Agreement℠ financial
"entered into an Open Market Sale Agreement℠ (the “Sales Agreement”) with Jefferies LLC"
at the market offering program financial
"through the at the market offering program pursuant to the Sales Agreement"
General Instruction I.B.6 regulatory
"pursuant to General Instruction I.B.6, often referred to as the “baby shelf” rule"
baby shelf financial
"often referred to as the “baby shelf” rule, because the Company’s public float was below $75 million"
public float financial
"the aggregate market value of the Company’s public float, calculated according to General Instruction I.B.6"
Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.
General Instruction I.B.1 regulatory
"the Company is relying on General Instruction I.B.1 of Form S-3"
false 0001943289 0001943289 2026-05-08 2026-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 8, 2026

 

Silvaco Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

Delaware   001-42043   27-1503712
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

Silvaco Group Inc.

4701 Patrick Henry Drive, Building #23

Santa Clara, CA 95054

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (408) 567-1000

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   SVCO   The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01 Other Items.

 

As previously reported, on March 13, 2026, Silvaco Group, Inc. (the “Company”) entered into an Open Market Sale Agreement℠ (the “Sales Agreement”) with Jefferies LLC (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time, at its option through the Sales Agent, shares of the Company’s common stock, $0.0001 par value per share (the “Shares”). The Shares are issued pursuant to the Company’s registration statement on Form S-3 (File No. 333-291212), which became effective on November 21, 2025, and the related prospectus supplement dated March 13, 2026 (the “ATM Prospectus Supplement”) registering the offer and sale of Shares in an aggregate offering amount of up to $15.0 million, in each case filed with the Securities and Exchange Commission (the “SEC”).

 

On May 8, 2026, the Company filed a prospectus supplement (the “Prospectus Supplement”) amending and supplementing the ATM Prospectus Supplement to reflect an increase in the Company’s existing at the market offering program to allow for the issuance of an additional $20.0 million in shares of the Company’s common stock, for a total of $35.0 million (inclusive of any amounts previously sold by the Company). As of May 7, 2026, the Company has sold 752,744 shares of common stock with an aggregate offering price of approximately $4,331,280 through the at the market offering program pursuant to the Sales Agreement. Therefore, we may offer and sell an aggregate of up to $30,668,720 of shares of the Company’s common stock pursuant to the Prospectus Supplement.

 

The Company previously offered and sold securities under its shelf registration statement on Form S-3 (File No. 333-291212) pursuant to General Instruction I.B.6, often referred to as the “baby shelf” rule, because the Company’s public float was below $75 million. Based on the reported sale price of the Company’s common stock of $12.46 per share, as reported on the Nasdaq Global Select Market on May 6, 2026, the aggregate market value of the Company’s public float, calculated according to General Instruction I.B.6. of Form S-3, is $175,270,596 based on 32,688,557 shares of the Company’s common stock outstanding as of May 6, 2026, of which 14,066,661 shares are held by non-affiliates. As the aggregate market value of the Company’s outstanding common equity held by non-affiliates exceeded $75 million, the Company is no longer subject to the baby shelf limitation on the amount of securities it may sell. Consequently, the Company is relying on General Instruction I.B.1 of Form S-3 and may offer and sell additional securities without the prior 12-month limitations under General Instruction I.B.6.

 

A copy of the legal opinion of White & Case LLP relating to the validity of the additional Shares of common stock being offered pursuant to the Sales Agreement is filed as Exhibit 5.1 to this Current Report on Form 8-K.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares discussed herein, nor shall there be any offer, solicitation, or sale of the Shares in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.   Description
5.1   Opinion of White & Case LLP.
23.1   Consent of White & Case LLP (contained in Exhibit 5.1).
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 8, 2026 SILVACO GROUP, INC.
     
  By: /s/ Christopher Zegaralli
    Christopher Zegaralli
    Chief Financial Officer

 

2 

 

FAQ

What did Silvaco Group, Inc. (SVCO) change in its at-the-market offering?

Silvaco increased its at-the-market common stock offering capacity to $35.0 million. The company filed a new prospectus supplement allowing an additional $20.0 million in stock sales under its existing Open Market Sale Agreement with Jefferies LLC.

How much has Silvaco (SVCO) already sold under the ATM program?

Silvaco has sold 752,744 shares of common stock for an aggregate offering price of approximately $4,331,280. These shares were sold through the at-the-market offering program pursuant to the company’s Open Market Sale Agreement with Jefferies LLC.

How much capacity remains in Silvaco’s (SVCO) at-the-market program?

Silvaco may offer and sell up to $30,668,720 of common stock under the updated prospectus supplement. This remaining capacity reflects the new total $35.0 million program minus amounts already sold through the at-the-market facility.

Why is Silvaco (SVCO) no longer subject to the baby shelf limitation?

Silvaco’s public float reached $175,270,596, exceeding the $75 million threshold. This was calculated under Form S-3 General Instruction I.B.6 using a share price of $12.46 and 14,066,661 non-affiliate shares, removing the “baby shelf” constraints.

What Form S-3 instruction does Silvaco (SVCO) now rely on for offerings?

Silvaco now relies on General Instruction I.B.1 of Form S-3. Because its public float is above $75 million, the company is no longer limited by the rolling 12‑month “baby shelf” cap under General Instruction I.B.6 for registered offerings.

Which registration statement and filings cover Silvaco’s (SVCO) ATM program?

The at-the-market program uses Silvaco’s Form S-3 registration statement (File No. 333-291212). It is implemented through an Open Market Sale Agreement with Jefferies and related prospectus supplements dated March 13, 2026 and May 8, 2026.

Filing Exhibits & Attachments

4 documents